Showing results (1081-1090 of 2,297) with videos related to
Sort By:
Pageof 230
Clinical and Experimental Medicine|September 11, 2024
Identification of PFKFB3 as a key factor in the development of colorectal cancer and immunotherapy resistanceSi Lu, Rongjie Zhao, Yicheng Han, et al.Clinical and Experimental Medicine|October 9, 2024
Evaluating the impact of treatment sequencing on outcomes in hepatocellular carcinoma: a comparative analysis of TACE and systemic therapiesXingRong Zheng, Xin Song, BoXiang Zhang, et al.Clinical and Experimental Medicine|August 17, 2024
Impact of tumor multiplicity on the prognosis of patients with primary renal cell carcinoma: a SEER database analysisTianyue Yang, Hongfeng Zheng, Shaojun Chen, et al.Clinical and Experimental Medicine|August 14, 2024
Novel method for detecting frequent TERT promoter hot spot mutations in bladder cancer samplesÁkos Kovács, Farkas Sükösd, Levente Kuthi, et al.Clinical and Experimental Medicine|August 14, 2024
Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directionsGuanBo Zhang, JinSong Li, Gang Li, et al.Clinical and Experimental Medicine|August 13, 2024
The value of perforator flap reconstruction in painful soft tissue calcificationsLoraine Kouba, Adriano Fabi, Kathrin Glatz, et al.Clinical and Experimental Medicine|August 6, 2024
Angiogenesis in breast cancer: insights and innovationsGhada Elayat, Abdel SelimClinical and Experimental Medicine|October 19, 2024
Assessing the practice of total neoadjuvant therapy for rectal cancer: an online survey among radiation oncology departments in Germany and German-speaking regions of Austria and SwitzerlandStefan Knippen, Guido Hildebrandt, Florian Putz, et al.Clinical and Experimental Medicine|October 19, 2024
The role of trimethoprim/sulfamethoxazole in preventing opportunistic infections in systemic lupus erythematosus patients receiving low-level immunosuppressive treatment: an open-label, randomized, controlled trialPaopat Munthananuchat, Pintip Ngamjanyaporn, Prapaporn Pisitkun, et al.Clinical and Experimental Medicine|August 12, 2024
Real-world experience with CDK4/6 inhibitors in hormone receptor-positive metastatic and recurrent breast cancer: findings from an Asian populationBo-Fang Chen, Yi-Fang Tsai, Ta-Chung Chao, et al.Pageof 230